244. I@W X RoundsTable - Rare Diseases
The Intern At Work: Internal Medicine
00:00
Clinical Trial Insights on RNA Interference for Rare Diseases
This chapter explores a phase three clinical trial of an RNA interference agent designed to treat ATTR cardiac amyloidosis. It discusses the trial's methodology, including patient demographics, key exclusion criteria, and the outcomes measured over a 12-month period.
Transcript
Play full episode
